Measurement of spironolactone metabolites in patients with heart failure and preserved ejection fraction enrolled in the TOPCAT trial: New insights into regional variation
Q&A
Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study
Q&A
Serve-HF Post Hoc Analysis
Q&A
Adaptive Servo-Ventilation reduces Atrial Fibrillation Burden in Patients with Heart Failure and Sleep Apnea: Results from the CAT-HF Arrhythmia Substudy
Q&A
Baseline Characteristics and Safety of Empagliflozin (EMPA) in US patients enrolled in the EMPA REG OUTCOME trial
Q&A

John McMurray